Arrowhead Pharmaceuticals Inc (ARWR) Common Stock USD0.001
Sell:$25.69Buy:$25.70
$3.71
(16.84%)
NASDAQ:
0.82%
0.82%Market closed |
Prices delayed by at least 15 minutes
- This stock can be held in a
Create an alert
Stocks and Shares ISASell:$25.69
Buy:$25.70
Change:$3.71
(16.84%)
$3.71
(16.84%)Market closed |
Prices delayed by at least 15 minutes
Sell:$25.69
Buy:$25.70
Change:$3.71
(16.84%)
$3.71
(16.84%)Market closed |
Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 August 2025 | James C. HamiltonOther Level A | Sell Regular sell transaction (market) | 9,389 | $20.00 | $187,780.00 | 262,122 |
| 13 August 2025 | James C. HamiltonOther Level A | Sell Regular sell transaction (market) | 611 | $20.00 | $12,220.00 | 271,511 |
| 11 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 50,800 | $11.49 | $583,692.00 | 3,921,255 |
| 10 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 50,000 | $10.87 | $543,500.00 | 3,972,055 |
| 9 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 35,305 | $9.93 | $350,578.65 | 4,027,072 |
| 9 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 3,400 | $10.75 | $36,550.00 | 4,023,672 |
| 9 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 1,617 | $11.76 | $19,015.92 | 4,022,055 |
| 13 March 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 51,425 | $15.07 | $774,974.75 | 4,062,377 |
| 4 March 2025 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 133,333 | $17.02 | $2,269,327.66 | 3,773,802 |
| 3 March 2025 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 166,667 | $18.03 | $3,005,006.01 | 3,907,135 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 March 2025 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 166,667 | $18.03 | $3,005,006.01 | 3,907,135 |
| 4 March 2025 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 133,333 | $17.02 | $2,269,327.66 | 3,773,802 |
| 13 March 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 51,425 | $15.07 | $774,974.75 | 4,062,377 |
| 11 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 50,800 | $11.49 | $583,692.00 | 3,921,255 |
| 10 April 2025 | Christopher Richard AnzalonePresident/CEO | Sell Tax related | 50,000 | $10.87 | $543,500.00 | 3,972,055 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.